LifeScience Biologics

Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.

 Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...

 July 19, 2023 | News

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

9MW2921 is a next generation antibody-drug conjugate (ADC) developed by Mabwell based on IDDC™ (Interchain-Disulfide Drug Conjugate) platef...

 July 19, 2023 | News

Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions

PreFluid is a leader in integrated fluid solutionsPreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental indus...

 July 19, 2023 | News

Scribe Therapeutics and Sanofi Team Up to Advance In Vivo Genetic Medicines for Sickle Cell and Genomic Disease

Predicated on the progress of the companies’ first collaboration, Sanofi has selected Scribe’s novel CRISPR by Design™ approach to driv...

 July 18, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

-  ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

 July 18, 2023 | News

Lonza Launches TheraPRO® CHO Media System

Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system i...

 July 17, 2023 | News

Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation

  Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...

 July 14, 2023 | News

Nona Biosciences and DualityBio Collaborate on Antibody Drug Conjugate (ADC): Business Update

Nona Biosciences entered into a collaboration agreement with DualityBio in 2022, pursuant to which Nona Biosciences granted the exclusive rights ...

 July 14, 2023 | News

Kedrion's global portfolio expands to China to supply human Albumin

Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world's largest ...

 July 13, 2023 | News

Velico Medical begins clinical trial on Spray Dried Plasma

This first in-human clinical trial using Velico's spray drying system is taking place at Hoxworth Blood Center, Cincinnati, Ohio; Versiti Blood Center...

 July 13, 2023 | News

Raya Therapeutic announces early-stage R&D collaboration with argenx

"We are delighted to be entering this early-stage R&D collaboration with argenx. argenx is one of the industry's most exciting companies, and their bel...

 July 13, 2023 | News

Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation

  Fast Track Designation (FTD) aims to facilitate the development of drugs targeting severe or life-threatening diseases that have the potential to a...

 July 12, 2023 | News

TCI Unveils VeCollal®: Biomimetic Collagen Mirroring Human Collagen, Validated by Belgian Clinical Study

In recent years, the growing awareness among consumers regarding environmental protection and health has driven the demand for vegan collagen. This growing...

 July 12, 2023 | News

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...

 July 12, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close